TNF-inhibition with etanercept for graft versus host disease prevention in high risk HCT: Lower TNFR1 levels correlate with better outcomes

PURPOSE: Graft-versus-host disease (GVHD) causes most non-relapse mortality (NRM) following alternative donor (unrelated and mismatched related) hematopoietic cell transplant (HCT). We previously showed that increases in day +7 TNF-receptor-1 (TNFR1) ratios (post-transplant day +7/pre-transplant bas...

詳細記述

保存先:
書誌詳細
主要な著者: Choi, Sung W., Stiff, Patrick, Cooke, Kenneth, Ferrara, James L.M., Braun, Thomas, Kitko, Carrie, Reddy, Pavan, Yanik, Gregory, Mineishi, Shin, Paczesny, Sophie, Hanauer, David, Pawarode, Attaphol, Peres, Edward, Rodriguez, Tulio, Smith, Scott, Levine, John E.
フォーマット: Artigo
言語:Inglês
出版事項: 2012
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3443302/
https://ncbi.nlm.nih.gov/pubmed/22469883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2012.03.013
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料